Outcome of the Board Meeting held on 05th November 2026.

05th November 2026 To To The Listing Department, The Corporate Relations Department, National Stock Exchange of India Limited BSE Limited NSE Symbol: SAILIFE BSE Scrip code: 544306 Dear Sir/Madam, Ref: Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 (“SEBI Listing Regulations”). Sub: Outcome of the Board Meeting held on Thursday, 05th November 2026. Referring to our letter dated 01st October 2026, we hereby inform you that, the Board of Directors at their meeting held on today i.e., Thursday, 05th November 2026, has inter-alia considered and approved the following matters: - 1. Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30th September 2026. In terms of the above, we enclose herewith the following: A. Unaudited Standalone and Consolidated Financial Results of the Company for the second quarter and half year ended 30th September 2026; and B. Limited review Reports on the Standalone & Consolidated Financial Results for the second quarter and half year ended 30th September 2026. 2. Based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors has approved the appointment of following persons as Senior Management Personnel (SMP) of the Company with effect from 05th November 2026: A. Mr. Sidhartha Das as Senior Vice President & Head - Human Resources; B. Mr. Vijay Kumar Suthari as Vice President - Head Quality & Regulatory Affairs; C. Mr. Sriram Gopalakrishnan as Senior Vice President - Corporate Communications. The details as required under Regulation 30 of the SEBI Listing Regulations read along with SEBI Master Circular No. HO/49/14/14(7)2025-CFD- POD2/I/3762/2026 dated 30th January 2026 are given as Annexure-A. 3. Allotment of 27,005 and 81,000 fully paid-up equity shares having a face value of ₹1/- each upon exercise of options granted under Employees Stock Option Plan Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. 2008 (ESOP 2008) and Management Employee Stock Option Plan 2018 (MESOP 2018) respectively. Consequent to aforesaid allotment the issued, subscribed, and paid-up equity share capital of the Company has increased from ₹21,24,72,716/- to ₹21,25,80,721/-. The details required under Regulation 10(c) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 (“SEBI ESOP Regulations 2021”) are enclosed herewith as Annexure-B. The Board Meeting commenced at 09:20 P.M. and concluded at 09:42 P.M. (IST). Kindly take the above information on your record. Thanking you. Yours sincerely, For Sai Life Sciences Limited Runa Karan Company Secretary & Compliance Officer Membership No. A13721 Encl.: As Above Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey Plot No. DS-7, IKP Knowledge Park, Turkapally F: +91 40 6815 6199 #133, Gachibowli Miyapur Road, (V), Shameerpet Mandal, Medchal-Malkajgiri E: info@sailife.com Gachibowli, Hyderabad – 500032, (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Telangana, India. Annexure-A Details as per Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026 Particulars Details Details Details Reason for Change viz. appointment, Appointment of Mr. Sidhartha Das Appointment of Mr. Vijay Kumar Appointment of Mr. Sriram reappointment, as Senior Vice President & Head - Suthari as Vice President - Head Gopalakrishnan as Senior Vice President resignation, removal, Human Resources, designated and Quality & Regulatory Affairs, - Corporate Communications, death or otherwise classified as Senior Management designated and classified as Senior designated and classified as Senior Personnel (SMP) Management Personnel (SMP) Management Personnel (SMP) Date of appointment/ Reappointment /cessation (as 05th November 2026 05th November 2026 05th November 2026 applicable) and term of appointment /reappointment Brief Profile (in case of Mr. Sidhartha Das is a seasoned Mr. S. Vijay Kumar is a seasoned Mr. Sriram Gopalakrishnan is a seasoned appointment) Human Resources professional with pharmaceutical industry professional marketing and communications over 25 years of diverse and rich with over 24 years of extensive professional with over 25 years of experience across the Fast-Moving experience in Quality Assurance, diverse experience in brand strategy, Consumer Goods (FMCG), Quality Control, Regulatory corporate communications, stakeholder Pharmaceuticals, Life Sciences, and Compliance, Quality Systems, and engagement, and reputation Infrastructure sectors. He holds a Operational Excellence across leading management across various industries. Master's degree in Social Work and pharmaceutical organizations. has completed his Executive MBA He has been associated with the from XLRI. In his previous stint he was associated company since November 2018 and has with Dr. Reddy’s Laboratories Limited, contributed significantly to where he was responsible for strengthening the Company's brand Sai Life Sciences Limited (CIN: L24110TG1999PLC030970) Corporate office Registered office Contact us T: +91 40 6815 6000, # L4-01 & 02, SLN Terminus, Survey #133, Gachibowli Plot No. DS-7, IKP Knowledge Park, Turkapally (V), Shameerpet Mandal, F: +91 40 6815 6199 Miyapur Road, Gachibowli, Hyderabad – 500032, Medchal-Malkajgiri E: info@sailife.com Telangana, India. (Dist), Hyderabad -500078, Telangana, India. W: www.sailife.com Mr. Das possesses extensive overseeing quality operations, positioning, corporate visibility, and expertise across the entire spectrum strengthening quality management communication initiatives during a of Human Resources management, systems, driving compliance initiatives, transformative phase of its growth including talent management, and supporting global regulatory journey. organizational development, inspections. He has also been associated employee relations, leadership with reputed organizations including Prior to joining Sai Life Sciences, Mr. development, merger and Novartis India Limited, AMRI (Albany Gopalakrishnan held leadership roles at acquisition integration, and strategic Molecular Research Inc.) and Pfizer Dr. Reddy's Laboratories and the Indian HR transformation. He has India Limited, where he played a School of Business (ISB), where he was successfully contributed to two significant role in quality assurance, responsible for driving strategic greenfield projects and has hands-on regulatory compliance, validation, marketing, brand-building, stakeholder experience in managing post- audit management, and continuous engagement, and institutional outreach acquisition integration and merger improvement initiatives. initiatives. Earlier in his career, he processes involving multiple worked with leading advertising organizations. Over the course of his career, he has agencies including Ogilvy, Lowe gained extensive experience in Worldwide, and RK Swamy BBDO, Over the course of his career, he has managing quality systems, cGMP gaining extensive experience in worked extensively in both domestic compliance, quality risk management, advertising, brand management, and and international environments, change control, deviations, CAPA integrated marketing communications. collaborating with diverse cultural implementation, vendor qualification, and business landscapes across process validation, and regulatory Mr. Gopalakrishnan holds a Bachelor's Europe, North America, Bangladesh, inspections. He has successfully degree in Commerce from the Univer [Showing first 8,000 characters — download PDF for full document]